RecruitingNCT05883995

Avis-PHAGEinLYON Clinic


Sponsor

Hospices Civils de Lyon

Enrollment

1,500 participants

Start Date

Feb 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.


Eligibility

Inclusion Criteria2

  • \- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028.
  • Avis-PHAGEinLYON clinic study information notice provided to the patient

Exclusion Criteria1

  • \- Opposition of trial participant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhage therapy requests

Quantification of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028


Locations(1)

Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05883995


Related Trials